Moreover, its insulin-sensitizing effects in the brain would complement these actions, and the amelioration of insulin resistance in the periphery would not only correct plasma hyperinsulinemia and decreased availability of insulin in the CSF, but also the highly pathogenic sequalae of insulin resistance on the quality of health and the lifespan. The gene discussed is INS; the disease is Hyperinsulinemia.